Investors FAQs

What are Syngenta’s corporate headquarters address and telephone number?

The global headquarter of Syngenta is located in Basel, Switzerland:
Syngenta International AG
P.O. Box
CH-4002 Basel
Switzerland
Phone: +41 61 323 11 11

What is Syngenta’s vision & main areas of activity?

Syngenta is one of the world's leading companies with more than 27,000 employees in some 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.

Click here to learn more about us.

How often is your Web site updated?

The Investor and Media Centers are updated frequently. Our Stock Information is updated several times per hour. Most of the general information on the site will not be updated as often because it is unlikely to become dated.

What is Syngenta’s Stock Ticker and what exchange is Syngenta traded on?

Syngenta is listed on the Swiss stock exchange (SYNN) and in New York (SYT).

Syngenta AG
Exchange: SIX Swiss ( Zurich ) Currency: CHF Symbol: SYNN
Syngenta AG (ADR)
Exchange: NYSE ( New York ) Currency: USD Symbol: SYT

How do I get printed copies of Syngenta’s financial information?

You can order printed copies of the complete audited financial statements by contacting us here:

By e-mail

Or write us to the following address:

Syngenta International AG
Investor Relations
Schwarzwaldallee 215
P.O. Box
CH-4002 Basel
Switzerland

When is the company's year end?

December 31st

Who is your independent auditor?

Ernst & Young was appointed as Group auditor at the Annual General Meeting in April 2002. The appointment of the auditor is for one year, renewable annually.

What currency are your financial statements prepared?

Our consolidated financial results are prepared in US dollars in accordance with International Financial Reporting Standards (“IFRS”).

When does the next Annual General Meeting (“AGM”) take place?

The next AGM will take place on April 29, 2014.

Click here for more information on our Calendar of Events.

Who are Syngenta's key management members?

Name Date of birth Nationality Function Appointment
Michael Mack 19.04.1960 American Chief Executive Officer 2008
John Atkin 01.09.1953 British Chief Operating Officer 2000
Robert Berendes 14.02.1965 German Head of Business Development

Ad Interim Head of Research & Development
2007
Caroline Luscombe 28.02.1960 British Head of Human Resources 2012
Christoph Mäder 21.07.1959 Swiss Head of Legal & Taxes
and Company Secretary
2000
Mark Peacock 02.02.1961 British Head of Global Operations 2007
Davor Pisk 16.03.1958 British Chief Operating Officer 2008
John Ramsay 03.10.1957 British Chief Financial Officer 2007

Click here to learn more about our Executive Committee.

How many employees does Syngenta have?

To meet the needs of individual markets, we have a global total of more than 27,000 people in over 90 countries.

What are your key financial targets?

As part of the implementation of our new strategy our financial objectives are based upon three key measures: EBITDA margin, cash flow return on investment and cash return to shareholders.

We are targeting an EBITDA margin of 22-24% by 2015 thereby reflecting our continued commitment to profitable growth.

We use cash flow return on investment targeting to maintain a level in excess of 12%, which represents a commitment to continuing strong cash generation at attractive levels of return on investment.

We will continue to return significant cash to shareholders. This will be through a cash return policy which prioritizes dividend growth. Share buybacks will be used tactically when the balance sheet and acquisition outlook allows.

What levels of cash do you return to your shareholders?

We expect strong cash generation to continue as an ongoing feature of our business. This will provide us with the flexibility to target a continuous increase in the dividend as well as continue to seek out acquisitions.

The total cash return for the period 2005-2012 was over $6.3 billion.

In 2011, a dividend of CHF 7.00 per share was paid on 28 April 2011 representing a cash return of $705 million. In addition we completed a further $198 million share repurchase in 2011.

In 2012 a dividend of CHF 8.00 per share was approved at the AGM on 24 April, 2012 and paid in cash on 02 May 2012 representing a cash return of $791 million.

What do you pay to your shareholders in the form of dividends?

The 2013 dividend was CHF 9.50 and was paid in cash on 30 April 2013 based on an ex-dividend date of 23 April 2013.

The 2012 dividend was CHF 8.00 and was paid in cash on 02 May 2012 based on an ex-dividend date of 26 April 2012.

The 2011 dividend was CHF 7.00 and was paid in cash on 28 April 2011 based on an ex-dividend date of 21 April 2011. It was paid from our share premium reserves, rendering it free from withholding tax.

The 2010 dividend was CHF 6.00 and was paid in cash on 27 April 2010 based on an ex-dividend date of 22 April 2010.

The 2009 dividend was CHF 6.00 and was paid in cash on 24 April 2009 based on an ex-dividend date of 24 April 2009.

What is your Weighted Average Cost of Capital (“WACC”)?

Our WACC is estimated at approximately 6.1%.

What are your debt ratings?

S&P: A
Moody's: A2

Both rating agencies reviewed Syngenta in the second half of 2012 and reconfirmed their ratings based on our leading market positions, high level of geographical diversification, strong business profile supported the track-record of delivering innovative solutions, and our balanced approach to managing growth and shareholder returns.

Where can I obtain more information?

You can reach our Investor Relations team via email or on the following numbers:

Jennifer Gough Switzerland Direct line +41 (0)61 323 5059
  USA Alternate +1 (202) 737 6521
Lars Oestergaard Switzerland Direct line +41 (0)61 323 6793
  USA Alternate +1 (202) 737 6520

This site contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefore.